These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 3099236)

  • 1. Prolactin secretion after surgery or bromocriptine treatment of prolactinoma.
    De Leo V; Petraglia F; Sardelli S; Danero S; Genazzani AR; D'Antona N
    Obstet Gynecol; 1987 Jan; 69(1):99-103. PubMed ID: 3099236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective regulation of prolactin secretion after successful removal of prolactinomas.
    Camanni F; Ghigo E; Ciccarelli E; Massara F; Campagnoli C; Molinatti G; Müller EE
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1270-6. PubMed ID: 6415087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromocriptine treatment of microprolactinomas: evidence of stable prolactin decrease after drug withdrawal.
    Moriondo P; Travaglini P; Nissim M; Conti A; Faglia G
    J Clin Endocrinol Metab; 1985 Apr; 60(4):764-72. PubMed ID: 3919052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothalamic-pituitary function following bromocriptine therapy in patients with prolactinomas.
    Badawy SZ; Notman DD; Sunderlin FS; Springer JM; Streeten DH; Omar MM; Marshall LD
    J Reprod Med; 1982 Mar; 27(3):139-45. PubMed ID: 6806469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macroprolactinomas and functionless pituitary tumours. Immunostaining and effect of dopamine agonist therapy.
    Gasser RW; Mueller-Holzner E; Skrabal F; Finkenstedt G; Mayr U; Tabarelli M; Spoendlin H; Grunert V; Twerdy K
    Acta Endocrinol (Copenh); 1987 Oct; 116(2):253-9. PubMed ID: 3116800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin and thyrotropin responses to thyrotropin-releasing hormone in patients with secondary amenorrhea: the effect of bromocriptine.
    Hirvonen E; Ranta T; Seppäla M
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1024-30. PubMed ID: 819453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas.
    Jones TH; Figueroa CD; Smith CM; Bhoola KD
    Agents Actions Suppl; 1992; 38 ( Pt 2)():175-82. PubMed ID: 1462825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal regulation of prolactin release by human prolactinoma cells cultured in serum-free conditions.
    Jaquet P; Gunz G; Grisoli F
    Horm Res; 1985; 22(3):153-63. PubMed ID: 3932176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary hyperprolactinemic amenorrhea. Report of 4 patients].
    Rudolf K; Smid I; Kunkel S; Bazsa-Kassai Z
    Zentralbl Gynakol; 1985; 107(14):894-8. PubMed ID: 3929499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is idiopathic hyperprolactinemia a transitional stage toward prolactinoma?
    Pereira MC; Sobrinho LG; Afonso AM; Ferreira JM; Santos MA; Sousa MF
    Obstet Gynecol; 1987 Sep; 70(3 Pt 1):305-8. PubMed ID: 3114691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low recurrence rate after partial hypophysectomy for prolactinoma: the predictive value of dynamic prolactin function tests.
    Webster J; Page MD; Bevan JS; Richards SH; Douglas-Jones AG; Scanlon MF
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):35-44. PubMed ID: 1559298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
    Teramoto A; Sanno N; Tahara S; Osamura YR
    Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of thyrotropin-releasing hormone and bromoergocriptine on growth hormone and prolactin secretion in perfused pituitary adenoma tissues of acromegaly.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1251-6. PubMed ID: 122426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of abnormal dopaminergic control of prolactin in patients with hypothalamic and pituitary tumors.
    Cabranes JA; Almoguera I; del Olmo J; Prensa A; Pablos I; Charro AL
    J Med; 1986; 17(1):25-39. PubMed ID: 3035040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human pituitary adenoma secreting thyrotropin and prolactin: immunohistochemical, biochemical, and cell culture studies.
    Jaquet P; Hassoun J; Delori P; Gunz G; Grisoli F; Weintraub BD
    J Clin Endocrinol Metab; 1984 Nov; 59(5):817-24. PubMed ID: 6480809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perifusion studies of bromocriptine-treated and untreated macroprolactinomas: effects of dopamine, bromocriptine and TRH.
    Bevan JS; Burke CW
    Clin Endocrinol (Oxf); 1989 Jun; 30(6):667-80. PubMed ID: 2512041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid regression of pituitary prolactinomas during bromocriptine treatment.
    Thorner MO; Martin WH; Rogol AD; Morris JL; Perryman RL; Conway BP; Howards SS; Wolfman MG; MacLeod RM
    J Clin Endocrinol Metab; 1980 Sep; 51(3):438-45. PubMed ID: 6773972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alteration of prolactin secretion after transsphenoidal adenomectomy for prolactinomas].
    Yokoyama M
    No To Shinkei; 1990 Aug; 42(8):773-9. PubMed ID: 2223270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does bromocriptine block thyrotropin-releasing hormone-induced prolactin release during pregnancy?
    Ylikorkala O; Kivinen S; Rönnberg L; Viinikka L
    J Clin Endocrinol Metab; 1980 Mar; 50(3):600-2. PubMed ID: 6766949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.